The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
Open accessAbstract
Adenine base editing (ABE) enables enzymatic conversion from A-T into G-C base pairs. ABE holds promise for clinical application, as it does not depend on the introduction of double-strand breaks, contrary to conventional CRISPR/Cas9-mediated genome engineering. Here, we describe a cystic fibrosis (CF) intestinal organoid biobank, representing 664 patients, of which ~20% can theoretically be repaired by ABE. We apply SpCas9-ABE (PAM recognition sequence: NGG) and xCas9-ABE (PAM recognition sequence: NGN) on four selected CF organoid samples. Genetic and functional repair was obtained in all four cases, while whole-genome sequencing (WGS) of corrected lines of two patients did not detect off-target mutations. These observations exemplify the value of large, patient-derived organoid biobanks representing hereditary disease and indicate that ABE may be safely applied in human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have previously described the use of ABEs in Cystic Fibrosis patient-derived organoids to functionally repair mutations in CFTR without genome-wide off-targets31.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While base editors have been applied before in organoids to model36 and repair31 diseases, we significantly extend their application by demonstrating the opportunities that reside in multiplexing CBE’s and ABE’s, as well as Cas9 homologs and evolved Cas9 variants.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Self-citationHigh-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 223
Organoids in drug development: from predictive models to regulatory integration
Song, X., Chen, X., Chen, Q., Wang, H., Zhang, T., Liao, M. Z., Liu, C., Yu, H., Hao, Y., Gu, G., et al. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104608 · Cited by 20
Stem Cell–Derived Respiratory Epithelial Cell Cultures as Human Disease Models
Orr, J. C., & Hynds, R. E. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0440tr · Cited by 15
A Perspective on a Urine-Derived Kidney Tubuloid Biobank from Patients with Hereditary Tubulopathies
Schutgens, F., Rookmaaker, M. B., & Verhaar, M. C. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2020.0366 · Cited by 14
A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines
Murthy, N. T. V., Vlasova, K. Y., Renner, J., Jozić, A., & Sahay, G. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115305 · Cited by 16
Binucleated human hepatocytes arise through late cytokinetic regression during endomitosis M phase
Darmasaputra, G., Geerlings, C. C., Lopes, S. M. C. D. S., Clevers, H. C., & Galli, M. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202403020 · Cited by 16
Self-citationBaghini, S. S., Gardanova, Z. R., Zekiy, A. O., Shomali, N., Tosan, F., & Jarahian, M. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.775309 · Cited by 16
RetractedCFTR RNA- and DNA-based therapies
Harrison, P. T. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102247 · Cited by 15
Production of CFTR-ΔF508 Rabbits
Yang, D., Liang, X., Pallas, B. D., Hoenerhoff, M. J., Ren, Z., Han, R., Zhang, J., Chen, Y. E., Jin, J., Sun, F., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.627666 · Cited by 15
Bioengineering toolkits for potentiating organoid therapeutics
Park, S., & Cho, S. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115238 · Cited by 18
Toward Inclusivity in Preclinical Drug Development: A Proposition to Start with Intestinal Organoids
Co, J. Y., Klein, J. A., Kang, S., & Homan, K. A. (2023) · Advanced Biology · doi:10.1002/adbi.202200333 · Cited by 15
Modelling adult stem cells and their niche in health and disease with epithelial organoids
Szabó, L., Seubert, A. C., & Kretzschmar, K. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.09.006 · Cited by 14
Genetically modified cell spheroids for tissue engineering and regenerative medicine
Jiang, Z., Xu, Y., Fu, M., Zhu, D., Li, N., & Yang, G. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.033 · Cited by 12
Kulhánková, K., Cheng, A. X., Traore, S., Auger, M., Pelletier, M., Hervault, M., Wells, K. D., Green, J. A., Byrne, A. K., Nelson, B., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae819 · Cited by 14
Open questions in human lung organoid research
Hughes, T., Dijkstra, K. K., Rawlins, E. L., & Hynds, R. E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1083017 · Cited by 13
Monitoring biological effects of somatic cell genome editing
Freedman, B., Bulte, J. W. M., Conklin, B. R., Judge, L. M., Dwinell, M. R., Geurts, A. M., Sitton, M. J., Mahajan, V., Kiani, S., Gersbach, C. A., et al. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-025-00916-0 · Cited by 13
Ricci, D., Cruciata, I., Fiduccia, I., Vitale, E., Corrao, F., Branchini, A., Carollo, P. S., Pibiri, I., & Lentini, L. (2025) · IUBMB Life · doi:10.1002/iub.70027 · Cited by 12
Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application
Kratzer, K., Getz, L. J., Peterlini, T., Masson, J., & Dellaire, G. (2021) · Human Genetics · doi:10.1007/s00439-021-02272-5 · Cited by 14
Tan, R., Du, W., Liu, Y., Cong, X., Bai, M., Jiang, C., Li, Z., Tan, M., Ma, D. K., Huang, Q., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.003 · Cited by 11
Development of novel therapeutics for all individuals with CF (the future goes on)
Amaral, M. D., & Harrison, P. T. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.10.007 · Cited by 12
Nanofabrication Technologies to Control Cell and Tissue Function in Three-Dimension
Otsuka, H. (2023) · Gels · doi:10.3390/gels9030203 · Cited by 11
Next-generation therapeutics for rare genetic disorders
Sankar, A. A., Ravi Kumar, Y. S., Singh, A., Roy, R., Shukla, R., & Verma, B. (2024) · Mutagenesis · doi:10.1093/mutage/geae002 · Cited by 13
Human Molecular Genetics and the long road to treating cystic fibrosis
Harris, A. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab191 · Cited by 11
Deconstructing cancer with precision genome editing
Johnson, G. A., Gould, S. I., & Rivera, F. J. S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230984 · Cited by 11
Intestinal organoids: The path towards clinical application
Sugihara, H. Y., Okamoto, R., & Mizutani, T. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151474 · Cited by 13
Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Taglieri, M., Gregorio, L. D., Matis, S., Uras, C. R. M., Ardy, M., Casati, S., Marchese, M., Poggi, A. D., Raffaghello, L., & Benelli, R. (2025) · Cells · doi:10.3390/cells14060457 · Cited by 12
A Concise Review of Organoid Tissue Engineering: Regenerative Applications and Precision Medicine
Makesh, K. Y., Navaneethan, A., Ajay, M., Munuswamy‐Ramanujam, G., Chinnasamy, A., Gnanasampanthapandian, D., & Palaniyandi, K. (2025) · Organoids · doi:10.3390/organoids4030016 · Cited by 12
Mini-organs with big impact: Organoids in liver cancer studies
Khawar, M. B., WANG, Y., MAJEED, A., AFZAL, A., Haneef, K., & Sun, H. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.029718 · Cited by 10
CRISPR for cystic fibrosis: Advances and insights from a systematic review
Nicosia, L., & Harrison, P. T. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.06.021 · Cited by 10
Yang, C., Yang, L., Feng, Y., Song, X., Bai, S., Zhang, S., & Sun, M. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2025.34 · Cited by 9
Joynt, A. T., Cutting, G. R., & Sharma, N. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.06.003 · Cited by 9
Chamorro-Herrero, I., & Zambrano, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054413 · Cited by 9
Convergence of human pluripotent stem cell, organoid, and genome editing technologies
Wang, L., Ye, Z., & Jang, Y.-Y. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370220985808 · Cited by 10
Cholon, D. M., & Gentzsch, M. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102210 · Cited by 10
Differentiation and CRISPR-Cas9-mediated genetic engineering of human intestinal organoids
Martínez-Silgado, A., Yengej, F. A. Y., Puschhof, J., Geurts, V., Boot, C., Geurts, M. H., Rookmaaker, M. B., Verhaar, M. C., Beumer, J., & Clevers, H. C. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101639 · Cited by 11
Self-citationDeciphering Breast Tumor Heterogeneity Through Patient-Derived Organoids and Circulating Tumor Cells
Policastro, B., Nissen, N., & Alves, C. L. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15070271 · Cited by 8
Advances in Biliary Disease Organoid Research: From Model Construction to Clinical Applications
Peng, B., Huang, M., Zhang, J., & Xiang, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501776 · Cited by 8
Nonsense-mediated mRNA decay: a key regulatory system engaged in cancer
Pan, H., Wu, X., Hu, B., Xiong, H., Luo, Y., & Zhou, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02503-6 · Cited by 8
The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells
Wong, P. K., Zamberi, N. N. M., Syafruddin, S. E., Cheah, F., Azmi, N., Law, J. X., & Chua, E. W. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0013 · Cited by 8
Gene therapy could offer an inclusive cure for cystic fibrosis
Khamsi, R. (2020) · Nature · doi:10.1038/d41586-020-02111-z · Cited by 8
Biomedical applications of organoids in genetic diseases
Huang, W., Jeong, S., Kim, W., & Chen, L. (2024) · Medical Review · doi:10.1515/mr-2024-0077 · Cited by 7
Innate Immunity and Asthma Exacerbations: Insights From Human Models
Alladina, J. W., Medoff, B. D., & Cho, J. L. (2025) · Immunological Reviews · doi:10.1111/imr.70016 · Cited by 10
Translational Utility of Organoid Models for Biomedical Research on Gastrointestinal Diseases
Banerjee, P., & Senapati, S. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10733-3 · Cited by 7
The application of organoids in colorectal diseases
Liu, Y., Wang, D., Luan, Y., Tao, B., Li, Q., Feng, Q., Zhou, H., Mu, J., & Yu, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1412489 · Cited by 8
Modeling pediatric AML FLT3 mutations using CRISPR/Cas12a- mediated gene editing
Rivera-Torres, N., Banas, K. H., & Kmiec, E. B. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1805740 · Cited by 7
Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing
Carrozzo, I., Maule, G., Gentile, C., Umbach, A., Ciciani, M., Guidone, D., Santis, M. D., Petris, G., Galietta, L. J. V., Arosio, D., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.011 · Cited by 6
Organoid-on-a-chip (OrgOC): Advancing cystic fibrosis research
Zheng, M., Erice, E., Wang, H., Zhang, L., & Lawrie, C. H. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102148 · Cited by 8
Organoid for Air Pollution Toxicity Assessment: Advances and Environmental Applicability
Jia, Y., Wu, D., Xiu, C., Ye, Z., & Li, Q. X. (2025) · Environment & Health · doi:10.1021/envhealth.5c00141 · Cited by 8
Application of organoids in otolaryngology: head and neck surgery
Zhu, H., Qu, S., Deng, Y., Gong, M., Xiang, Y., Teng, Y., & Ye, D. (2023) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-023-08348-4 · Cited by 6
Harnessing CRISPR technology for next-generation microphysiological systems
Song, S., Kang, H. W., Kang, M., Chung, S. H., Choi, N., Kim, H. N., & Sung, Y. J. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118164 · Cited by 6
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases
Johnson, P. A., Ackerman, J. E., Kurowska‐Stolarska, M., Coles, M. C., Buckley, C. D., & Dakin, S. G. (2023) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00190-x · Cited by 6
Cancer Risk and Mutational Patterns Following Organ Transplantation
Shen, Y., Lian, D., Shi, K., Gao, Y., Hu, X., Yu, K., Zhao, Q., & Feng, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.956334 · Cited by 6
Pathophysiology of Cystic Fibrosis Liver Disease
Kasper, V. L., & Assis, D. N. (2024) · Pediatric Pulmonology · doi:10.1002/ppul.26869 · Cited by 8
Genome-engineering technologies for modeling and treatment of cystic fibrosis
Dębczyński, M., Mojsak, D., Minarowski, Ł., Maciejewska, M., Lisowski, P., & Mróz, R. M. (2023) · Advances in Medical Sciences · doi:10.1016/j.advms.2023.02.003 · Cited by 5
Wang, X., Lin, D., & Feng, N. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03948-2 · Cited by 5
Lung stem cells and therapy for cystic fibrosis
Vaidyanathan, S., McCarra, M. B., & Desai, T. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10010520 · Cited by 5
Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis
Guimbellot, J. S., Nichols, D. P., & Brewington, J. J. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.06.005 · Cited by 5
Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023
Hynds, R. E., Magin, C. M., Ikonomou, L., Aschner, Y., Beers, M. F., Burgess, J. K., Heise, R. L., Hume, P. S., Krasnodembskaya, A. D., Mei, S. H. J., et al. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00052.2024 · Cited by 8
The Development and Application of a Base Editor in Biomedicine
Wang, F., Zeng, Y., Wang, Y., & Niu, Y. (2020) · BioMed Research International · doi:10.1155/2020/2907623 · Cited by 5
Cystic fibrosis as a paradigmatic disease in bringing science to the bedside
Amaral, M. D., & Pankonien, I. (2025) · FEBS Letters · doi:10.1002/1873-3468.70101 · Cited by 4
Organoid Models: Revolutionizing Disease Modeling and Personalized Therapeutics
Xue, Z., Yang, R., Liu, Y., & Luo, H. (2026) · Organoids · doi:10.3390/organoids5010009 · Cited by 5
Yan, Q., Liu, G., He, Y., Hou, S., Hao, K., Xing, J., Zhang, T., & Zhou, S. (2025) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2025.02.039 · Cited by 4
Zhang, H., Wan, Z., Li, X., Wang, B., Guan, J., Li, Y., Jin, X., Ma, X., & Liu, G. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04630-w · Cited by 4
Boeck, K. D., Burgel, P., Bierlaagh, M. C., Hill, K., Amaral, M. D., Birimberg‐Schwartz, L., Brewington, J. J., Davies, J. C., Karadag, B. T., Martin, U., et al. (2026) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2026.04.013 · Cited by 4
Self-citationAdvances in Off-Target Detection for CRISPR-Based Genome Editing
Wang, H., Wang, Y., Luo, Z., Lin, X., Liu, M., Wu, F., Shao, H., & Zhang, W. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.198 · Cited by 4
Tafech, B., Carlaw, T., Sadhnani, G., Schmidt, K., Morin, T., Leung, J., Weiner, J. M., An, K., Balázs, A., Ross, C. J., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114053 · Cited by 6
Self-citationNon-viral delivery of genome-editing tools for treatment of genetic disorders
Yang, J., Chen, Y., Chen, X., & Ping, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.02.014 · Cited by 3
Application and prospects of organoid-on-a-chip in research on the intestinal mucosal barrier
Qian, K., Wang, Y., Li, R. Q., Zhuang, M., Zhao, Z., Meng, C., Zhou, J., Wang, W., & Sun, Y. J. (2026) · Burns & Trauma · doi:10.1093/burnst/tkag029 · Cited by 4
Zhang, L., Wang, X., Yang, X., Chi, Y., Chu, Y., Zhang, Y., Gong, Y., Wang, F., Zhao, Q., & Zhao, D. (2024) · Biology · doi:10.3390/biology13090684 · Cited by 4
Non-viral mRNA cystic fibrosis therapies and their ongoing clinical trials
Gill, N. A., Fung, V., VanKeulen‐Miller, R., Narasipura, E. A., & Fenton, O. S. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2586172 · Cited by 3
Suer, J. A. L., Sease, R., Hawkins, F. J., & Ryan, A. L. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10010120 · Cited by 3
Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes
Liu, X., Zhou, X., Li, G., Huang, S., Sun, W., Sun, Q., Li, L., Huang, X., Liu, J., & Wang, L. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0036 · Cited by 3
Culture and Imaging of Human Nasal Epithelial Organoids
Liu, Z., Anderson, J. D., Natt, J., & Guimbellot, J. S. (2021) · Journal of Visualized Experiments · doi:10.3791/63064 · Cited by 3
Introducción a los sistemas CRISPR y sus aplicaciones en levaduras
Mendoza-Téllez, B., Zamora-Bello, A., Rosas-Paz, M., Villarreal-Huerta, D., de la Fuente-Colmenares, I., Segal‐Kischinevzky, C., & González, J. (2022) · TIP Revista Especializada en Ciencias Químico-Biológicas · doi:10.22201/fesz.23958723e.2022.502 · Cited by 2
Correcting CFTR: New Gene Editing Strategies for Rescuing CFTR Function Ex Vivo
Ryan, A. L. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.03.012 · Cited by 3
Organoids in Genetic Disorders: from Disease Modeling to Translational Applications
Zhu, Y., Lin, N., Li, J., Zhang, H., Zhang, P., Cheng, X., Yang, Q., & Liu, L. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10973-x · Cited by 2
Zhao, M., Guo, H., Kuang, L., Dai, J., Cao, X., Yu, K., Wang, Y., Wang, Z., & Peng, C. Y. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000004634 · Cited by 2
Research Advances and Disease Modeling in Respiratory Organoids
Chu, L., Chen, D., Jiang, S., Long, H., Liu, X., & Chen, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14010221 · Cited by 2
A Translational Roadmap for Neurological Nonsense Mutation Disorders
Li, J., Zhu, Z., & Xu, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031418 · Cited by 2
Multicellular systems to translate somatic cell genome editors to human
Hernandez‐Gordillo, V., Casolaro, T. C., Ebrahimkhani, M. R., & Kiani, S. (2020) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2020.100249 · Cited by 2
Genome Editing of Pluripotent Stem Cells for Adoptive and Regenerative Cell Therapies
Blassberg, R. A. (2022) · GEN Biotechnology · doi:10.1089/genbio.2021.0010 · Cited by 3
Bannier-Hélaouët, M., Geurts, M. H., Korving, J., Begthel, H., & Clevers, H. C. (2023) · Journal of Visualized Experiments · doi:10.3791/65040 · Cited by 2
Self-citationCystic fibrosis and other ion channel-related diseases
Graeber, S. Y., & Mall, M. A. (2023) · European Respiratory Society eBooks · doi:10.1183/2312508x.10018022 · Cited by 2
Self-citationSuppressor tRNA in gene therapy
Ruan, J., Yu, X., Xu, H., Cui, W., Zhang, K., Liu, C., Sun, W. A., Huang, X., An, L., & Zhang, Y. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2613-y · Cited by 2
Lee, D. D. H., Cardinale, D., Nigro, E., Butler, C. R., Rutman, A., Fassad, M. R., Hirst, R. A., MOULDING, D. A., Agrotis, A., Forsythe, E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.28.959189 · Cited by 2
Darmasaputra, G., Lopes, S. M. C. D. S., Clevers, H. C., & Galli, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.13.536716 · Cited by 4
Self-citationApplying the CRISPR/Cas9 for Treating Human and Animal Diseases – Comprehensive Review
Abdelnour, S. A., Salaka, A. S., Shakoori, A. M., Alsaffar, N., Hassanin, A. A., Abukhalil, M. H., & El-Hack, M. E. A. (2023) · Annals of Animal Science · doi:10.2478/aoas-2023-0009 · Cited by 1
Mechanics of serotonin-producing human entero-endocrine cells
Evers, T. M. J., Beumer, J., Clevers, H. C., & Mashaghi, A. (2024) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2024.100044 · Cited by 2
Self-citationNew Perspectives in Human Embryology
Wu, B. (2024) · Obstetrics and gynecology. · doi:10.5772/intechopen.1001771 · Cited by 1
Han, W., Lu, G., Zhao, S., Wang, R., Zhang, H., Liu, K., Nie, Y., & Dong, J. (2024) · Stem Cells International · doi:10.1155/2024/2005845 · Cited by 2
Enhancing anti-fibrotic therapy: nanomedicine approaches to overcome current limitations
Wu, L., Li, X., & Yang, L. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103253 · Cited by 1
Perspectives on Genetic Medicine for Cystic Fibrosis
Smirnikhina, S. (2022) · Current Gene Therapy · doi:10.2174/1566523222666220720102556 · Cited by 1
The research progress of correcting pathogenic mutations by base editing
Li, G., Zhang, Y., & Huang, X. (2024) · Obstetrics and gynecology. · doi:10.5772/intechopen.1004318 · Cited by 1
Toxicological Assessment In Vitro
Poussin, C., Iskandar, A. R., Mathis, C., Smart, D. J., Zanetti, F., van der Toorn, M., Bovard, D., Savioz, R., McHugh, D., Schlage, W. K., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820490-0.00018-3 · Cited by 1
Organoid systems for recapitulating the intestinal stem cell niche and modeling disease in vitro
Lim, H. Y. G., Kostic, L., & Barker, N. (2022) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2021.10.001 · Cited by 1
Sequence Diversification Screens with CRISPR‐Cas9‐Guided Base Editors
Persson, J., & Schmierer, B. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch11 · Cited by 1
Jeshvaghani, Z. S., Deenichina, P., Collen, L. V., de Vries, M. H., Brunsveld, J. E., Kotlarz, D., Koletzko, S., Klein, C., Beekman, J. M., Snapper, S. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.11.659065 · Cited by 1
Self-citationPersonalizing CFTR modulator therapies
Berkers, G. (2021) · doi:10.33540/68
Self-citationLatest Advances in Gene Therapy in Management of Cystic Fibrosis Lung Disease, Literature Review
Alghamdi, S. S., Alhamyani, N. M., Alamri, H. M., Alzahrani, T. S., Daghas, S. M., Bakri, R. H., Basehi, A. F., Almarashi, A. S., Alrajehi, A. M., & Ghanim, D. Z. A. (2021) · Journal Of Biochemical Technology · doi:10.51847/usni3jothd
Induced pluripotent stem cells
Calvert, B. A., Lorenzana, Z., Senger, C. N., Hsu, C.-Y., Busch, S. M., Koç-Günel, S., Quiroz, E. J., & Ryan, A. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823882-0.00003-5
Modelling of a wide variety of disease using adult stem cell-derived organoids
van der Vaart, J. Y. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/930
Metadata
- Authors
- Geurts, M. H., de Poel, E., Amatngalim, G. D., Oka, R., Meijers, F. M., Kruisselbrink, E., van Mourik, P., Berkers, G., de Winter-de Groot, K. M., Michel, S., Muilwijk, D., Aalbers, B. L., Mullenders, J., Boj, S. F., Suen, S. W. F., Brunsveld, J. E., Janssens, H. M., Mall, M. A., Graeber, S. Y., van Boxtel, R., van der Ent, C. K., Beekman, J. M., & Clevers, H.
- Affiliations
- Royal Netherlands Academy of Arts and Sciences (NL)
- Utrecht University (NL)
- Oncode Institute (NL)
- Erasmus MC (NL)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Beekman, Jeffrey M.
- Clevers, Hans
- ORCID
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 26
- Issue
- 4
- Pages
- 503-510.e7
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W3007694991
- Cited by
- 222
- References
- 46
- Citations by year
- 2026: 19 · 2025: 33 · 2024: 31 · 2023: 37 · 2022: 33 · 2021: 44 · 2020: 25
- FWCI
- 11.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell stem cell (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- Funders
- Cancer Research UK (C6307/A29058)
- Charité – Universitätsmedizin Berlin
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (737.016.009)
- Berlin Institute of Health
- Nederlandse Cystic Fibrosis Stichting
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- adenine base editing, cystic fibrosis, nonsense mutation, intestinal organoids, organoid biobank, gene correction, off-target mutations, genetic disorders, patient-derived cells
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, Adenine, Cystic Fibrosis, Humans, Organoids, Biological Specimen Banks, Codon, Nonsense, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
